PMID: 9422438Jan 1, 1997Paper

Differences in older versus younger hemodialysis patients' noncompliance with oral medications

Geriatric Nephrology and Urology
R B CurtinP Sacksteder

Abstract

Hemodialysis patients' compliance with their therapeutic regimens, including dietary and fluid restrictions, dialysis treatments and medications, is generally suboptimal. Recently, the mean age of the dialysis population has increased. Since impaired cognitive function, which sometimes accompanies aging, interferes with the ability to comprehend instructions, elderly dialysis patients might be at greater risk for noncompliance than are their younger counterparts. In this project, 135 hemodialysis patients (68 patients > 65 years of age and 67 patients < or = 65 years) were studied. Rates of noncompliance with oral antihypertensives and phosphate binders, as tracked by a medication event monitoring system (MEMS), are reported here. More than 42% of older patients (> 65) and 47% of younger patients (< or = 65) were repeated noncompliers with antihypertensives, missing at least 20% of the prescribed doses. Similarly, 65% of older patients and 80% of younger patients exhibited repeated noncompliance with phosphate binders. Almost 30% of older patients and more than 32% of younger patients missed their antihypertensives completely on 20% or more of the prescribed days. Only 18% of the older subjects, but 33% of younger patients miss...Continue Reading

Citations

May 6, 2005·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Richard T BlaszakDebbie R Brady
Apr 15, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Denis FouqueUNKNOWN Renilon Multicentre Trial Study Group
Dec 29, 1998·Current Opinion in Nephrology and Hypertension·S J Bander, B A Walters
Jan 29, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Joseph A ColadonatoWilliam F Owen
Sep 1, 2001·Journal of Advanced Nursing·S K PangA M Chang
Nov 28, 2002·Diabetes Care·Susan S GillilandKelly J Acton
Oct 28, 2005·Journal of the American Society of Nephrology : JASN·Joseph A Coladonato
Jul 2, 2011·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Diane L FrankenfieldKaryn K Anderson
Dec 23, 2015·Journal of Advanced Nursing·Esperanza Vélez-Vélez, Ricardo J Bosch
May 8, 2000·Journal of the American Geriatrics Society·W von Renteln-Kruse
Aug 4, 2004·Journal of Gerontological Nursing·Elizabeth A SchlenkSandra Engberg
Sep 24, 2004·Drugs & Aging·Carmel M Hughes
Jan 1, 1997·Seminars in Dialysis·R B CurtinP Sacksteder
Dec 5, 2015·PloS One·Saurav GhimireSyed Tabish R Zaidi
Apr 3, 2020·European Journal of Clinical Pharmacology·Steffen J SchmidtPetra A Thürmann
Jul 18, 2014·European Journal of Clinical Pharmacology·Marit TveitoGudrun Høiseth
Nov 22, 2008·Drugs & Aging·Sönke ArltWolfgang von Renteln-Kruse
Aug 30, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Lori D WaznyPeter G Blake
Aug 10, 2006·Néphrologie & thérapeutique·Evelyne RiemerYves Dimitrov
Dec 20, 2007·Néphrologie & thérapeutique·Menno T PruijmMichel Burnier
Aug 30, 2008·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·Kyung-Ae ParkSoon Bae Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.